Why the study?
Does low dose spironolactone reduce blood pressure in patients with resistant hypertension and type 2 diabetes mellitus?
Does low dose spironolactone reduce blood pressure in patients with resistant hypertension and type 2 diabetes mellitus?
Low-dose spironolactone significantly reduces ambulatory blood pressure and urinary albumin excretion when added to triple therapy in patients with type 2 diabetes and resistant hypertension.
No takes yet. Share an insight, caveat, or question.
Supports adding low-dose spironolactone to triple therapy in resistant hypertension with T2DM; extends RCT evidence for ambulatory BP reduction in this population.
Oxlund et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: